214 related articles for article (PubMed ID: 25992222)
1. Tumorigenesis: cell defense against hypoxia?
Pakravan N
Oncol Rev; 2013 Apr; 7(1):e1. PubMed ID: 25992222
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting Hypoxia and Chemotherapy-Induced Cancer Cell Metastasis under a Valid Therapeutic Effect by an Assistance of Biomimetic Oxygen Delivery.
Jiang MS; Yin XY; Qin B; Xuan SY; Yuan XL; Yin H; Zhu C; Li X; Yang J; Du YZ; Luo LH; You J
Mol Pharm; 2019 Nov; 16(11):4530-4541. PubMed ID: 31617723
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cell death in the tumor microenvironment.
Wouters BG; Koritzinsky M; Chiu RK; Theys J; Buijsen J; Lambin P
Semin Radiat Oncol; 2003 Jan; 13(1):31-41. PubMed ID: 12520462
[TBL] [Abstract][Full Text] [Related]
5. Tumor associated macrophages provide the survival resistance of tumor cells to hypoxic microenvironmental condition through IL-6 receptor-mediated signals.
Jeong SK; Kim JS; Lee CG; Park YS; Kim SD; Yoon SO; Han DH; Lee KY; Jeong MH; Jo WS
Immunobiology; 2017 Jan; 222(1):55-65. PubMed ID: 26705936
[TBL] [Abstract][Full Text] [Related]
6. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
Front Immunol; 2019; 10():407. PubMed ID: 30930892
[TBL] [Abstract][Full Text] [Related]
7. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.
DelNero P; Lane M; Verbridge SS; Kwee B; Kermani P; Hempstead B; Stroock A; Fischbach C
Biomaterials; 2015 Jul; 55():110-8. PubMed ID: 25934456
[TBL] [Abstract][Full Text] [Related]
8. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction.
McDonald PC; Chafe SC; Dedhar S
Front Cell Dev Biol; 2016; 4():27. PubMed ID: 27066484
[TBL] [Abstract][Full Text] [Related]
9. Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges.
Noman MZ; Hasmim M; Lequeux A; Xiao M; Duhem C; Chouaib S; Berchem G; Janji B
Cells; 2019 Sep; 8(9):. PubMed ID: 31540045
[TBL] [Abstract][Full Text] [Related]
10. Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency.
De Miguel MP; Alcaina Y; de la Maza DS; Lopez-Iglesias P
Curr Mol Med; 2015; 15(4):343-59. PubMed ID: 25941818
[TBL] [Abstract][Full Text] [Related]
11. A microfluidic oxygen sink to create a targeted cellular hypoxic microenvironment under ambient atmospheric conditions.
Barmaki S; Jokinen V; Obermaier D; Blokhina D; Korhonen M; Ras RHA; Vuola J; Franssila S; Kankuri E
Acta Biomater; 2018 Jun; 73():167-179. PubMed ID: 29649636
[TBL] [Abstract][Full Text] [Related]
12. Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis.
Yang M; Mu Y; Yu X; Gao D; Zhang W; Li Y; Liu J; Sun C; Zhuang J
Biomed Pharmacother; 2024 May; 176():116783. PubMed ID: 38796970
[TBL] [Abstract][Full Text] [Related]
13. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: drug discovery for targeting the tumor microenvironment.
Nagasawa H
J Pharmacol Sci; 2011; 115(4):446-52. PubMed ID: 21422725
[TBL] [Abstract][Full Text] [Related]
15. Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic process.
Ezhilarasan R; Mohanam I; Govindarajan K; Mohanam S
Int J Oncol; 2007 Mar; 30(3):701-7. PubMed ID: 17273772
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment: hypoxia and buffer capacity for immunotherapy.
Liu C; Gao S; Qu Z; Zhang L
Med Hypotheses; 2007; 69(3):590-5. PubMed ID: 17360127
[TBL] [Abstract][Full Text] [Related]
17. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.
Bussink J; Kaanders JH; van der Kogel AJ
Radiother Oncol; 2003 Apr; 67(1):3-15. PubMed ID: 12758235
[TBL] [Abstract][Full Text] [Related]
18. Tumors may modulate host immunity partly through hypoxia-induced sympathetic bias.
Joon Yun A; Bazar KA; Lee PY
Med Hypotheses; 2004; 63(2):352-6. PubMed ID: 15236802
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia and Hypoxia-Inducible Factors in Leukemias.
Deynoux M; Sunter N; Hérault O; Mazurier F
Front Oncol; 2016; 6():41. PubMed ID: 26955619
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference.
Choi SH; Park JY
Cancer Cell Int; 2017; 17():3. PubMed ID: 28053598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
